Champion Iron reports solid Q4 and FY2022 results

May 26, 2022

Champion Iron Limited (ASX: CIA) has released its operational and financial results for the fourth quarter and fiscal year ended 31 March 2022.

  • Revenue during March 2022 quarter stood at AU$331.4 million, which was AU$396.7 million in the previous corresponding period (pcp). FY2022 revenue stood at AU$1,460.8 million which was AU$1,281.8 million on pcp.
  • EBITDA during March 2022 quarter was AU$197.9 million, compared to AU$275.8 million on pcp. It was AU$925.8 million during the FY2022, compared to AU$819.5 million on pcp.
  • Net income for three months was AU$115.7 million compared to AU$155.9 million on pcp. The net income for FY2022 was AU$522.6 million, which was AU$464.4 million for the same period in 2021.
  • CIA paid inaugural dividend of AU$0.10 per ordinary share on 01 March 2022.
  • During the March 2022 quarter, CIA produced 1,869,000 wmt of high-grade 66.2% Fe concentrate, which was 2,011,400 wmt of high-grade 66.5% Fe concentrate on pcp. In FY2022, CIA produced 7,907,300 wmt of high-grade 66.2% Fe concentrate, which was 8,001,200 wmt of high-grade 66.4% Fe for the same period in 2021.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Maven Capital Pty Ltd (AFSL No. 418504). The information contained in this article is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Suite 1A, Level 2, 802-808 Pacific Highway, Gordon NSW 2072, Australia | 1800 005 780 | info@kapitales.com.au